Incidence of dry eye in rheumatoid arthritis and associated macular toxicity due to drug
Keywords:
rheumatoid arthritis, dry eye syndromes, DAS, Schirmer test, TBUT, OSDI, hydroxychloroquine, retinopathyAbstract
Background: “Dry eye” is used to describe a variety of conditions with diverse origins that affect the tear film and/or the ocular surface. [1]. Although it is well established that dry eye is frequently associated with Rheumatoid Arthritis (RA), the correlation between the severity of dry eye and the activity of RA is unclear. Patients suffering from RA commonly develop dry eye secondary to lymphocytic and plasma cell infiltrate of the lacrimal gland that lead to destruction of acini in the lacrimal glands Aim: To evaluate the incidence of dry eye in rheumatoid arthritis (RA) patients, and to investigate the effect of the routine Hydroxychloroquine drug therapy on the retina. Methods: In 75 RA patients, the severity of dry eye was assessed by the Schirmer I test, tear break-up time, rose Bengal staining, fluorescein staining and OSDI scoring. The RA activity was evaluated by the duration of the disease, Disease Activity Score (DAS)-28 score, Rheumatoid Factor, hs CRP and ESR levels. Results: The incidence of dry eye increased with the duration of rheumatoid arthritis. A strong correlation between RA factor levels and severity of dry eye was seen. OSDI was a reliable measure of dry eye symptoms.
Downloads
References
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
B.Narmadha, M.Ramkumar, K.Vengatesan, M.Srinivasan, “Household safety based on IOT”, International Journal of Engineering Development and Research, Pages:2321-9939, 2017.
Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45(Suppl 2):S211–220.
Cho P, Yap M. Schirmer test. I. A review. Optom Vis Sci. 1993;70:152-156.
D.Saravanan, Dr. T. Rammohan, Kukati Aruna Kumari, D.Raghu Raman, Abhijeet Manoj Dhulekar, Dr. D.Stalin David,” Using Machine Learning for Short-Term Extrapolation in Financial Forecast Based on Field-Programmable Gate Array”, Turkish Journal of Physiotherapy and Rehabilitation; 32(3) ISSN 2651-4451 | e-ISSN 2651-446X, Pages : 1252-1260.
Dr, D. Stalin David, Dr. G.Nageswara Rao, MahendraPratap Swain, Uriti Sri Venkatesh, E. FantinIrudaya Raj, D. Saravanan,” Inflammatory Syndrome Experiments Related with Covid-19”, Turkish Journal of Physiotherapy and Rehabilitation; 32(3) ISSN 2651-4451 | e-ISSN 2651-446X, Pages : 765 – 768.
Dr.P.Lakshmi, Dr.D.StalinDavid, Hemen I.Kalaria, S.Jayadatta, Dr.Anita Sharma, D.Saravanan,” Research on Collaborative Innovation of E-Commerce Business Model for Commercial Transactions “, Turkish Journal of Physiotherapy and Rehabilitation; 32(3) ISSN 2651-4451 | e-ISSN 2651-446X, Pages : 787 – 794.
Dr.Suresh Kumar Agarwal, Dr.Vimuktha E Salis, Dr.K.Bommanna Raja, Dr C Karthikeyini, Prem Shankar Gupta, D.Saravanan,” Experience of Treating Covid-19 with Hydroxychloroquine and Azithromycin: New Delhi, India”, Turkish Journal of Physiotherapy and Rehabilitation; 32(3) ISSN 2651-4451 | e-ISSN 2651-446X, Pages : 795-804.
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996). Rheumatoid arthritis. Cell .1996;85: 307–310.
Fujita M, Igarashi T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140(5):808–813.
Harper, S. L., & Foster, C. S. The ocular manifestations of rheumatoid disease. International Ophthalmology Clinics.1998; 38(1): 1–19.
Hochberg, M. C., Johnston, S. S., & John, A. K. (2008). The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly diagnosed patients with rheumatoid arthritis between 1999 and 2006. Current Medical Research and Opinion.2008; 24:469–480.
Jones DT, Monroy D, Ji Z, Pflugfelder SC. Alterations of ocular surface gene expression in Sjoegren’s syndrome. Adv Exp Med Biol. 1998;438:533–536.
Koteswara Rao Vaddempudi, Dr.G.Nageswara Rao, D.Saravanan, S.Sindhura, S.Gopa Kumar, Dr. D. Stalin David,” Marine Area Remote Sensing Monitoring Withadvanced Flight Regulator and Self-Directed Regulator”, Turkish Journal of Physiotherapy and Rehabilitation; 32(3) ISSN 2651-4451 | e-ISSN 2651-446X, Pages : 1584-1590.
Kranthi Kumar Singamaneni, Dr.G.Puthilibai, D.Saravanan, Dr.P,Sagaya Aurelia, P Gopala Krishna, Dr.D.Stalindavid,” An Effective Parkinson's Disease Prediction Using Logistic Decision Regression and Machine Learning with Big Data “, Turkish Journal of Physiotherapy and Rehabilitation; 32(3) ISSN 2651-4451 | e-ISSN 2651-446X, Pages : 778 – 786.
Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on human meibomian gland function and the ocular surface. J Clin Endocrinol Metab. 2000;85(12):4874– 4882.
Kujawa A, Rozycki R. Immunological phenomena in the pathology of the tear film. Is cyclosporine the turn point in Sjogren’s syndrome treatment? Preliminary report. Klin Oczna. 2004;106(3 Suppl):489– 491.
Lemp M. Basic principles and classification of dry eye disorders. New York: Springer, 1992:103–131.
Lemp MA. Report of the National Eye Institute/Industry Workshop
Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993;100(3):347– 351.
Moreland, L. W., & Curtis, J. R. (2009). Systemic nonarticular manifestations of rheumatoid arthritis: Focus on inflammatory mechanisms. Seminars in Arthritis and Rheumatism.2009; 39: 132–143.
Nichols KK, Nichols JJ, Mitchell G.L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762–770.
Piper H, Douglas KM, Treharne GJ, Mitton DL, Haider S, Kitas GD. Prevalence and predictors of ocular manifestations of RA: is there a need for routine screening? Musculoskeletal care. 2007;5(2):102-17.
Polanska V, Sery O, Fojtík Z, Hlinomazova Z. The presence of dry eye syndrome and corneal complications in patients with rheumatoid arthritis and its association with -174 gene polymorphism for interleukin 6. Cesk Slov Oftalmol. 2008;64:77-80.
Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U. Tumor necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol. 2003;87:548–550.
Reddy SC, Gupta SD, Jain IS, Deodhar SD. Ocular manifestations of rheumatoid Arthritis. Indian J Ophthalmol. 1977;25(3):20–26.
Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients of Sjogren syndrome. Ophthalmology. 1998;105(8):1485–1488.
Shimazaki JaDERGiJ. Definition and criteria of dry eye. Ganka 1995;37:765–770.
Solomon A, Dursun D, Lui Z, et al. Pro– and anti–inflammatory forms of interleukin–1 in the tear fluid and conjunctiva of patients with dry–eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283– 2292.
Tamhane A, Redden DT, McGwin G Jr, et al. Comparison of the disease activity score using erythrocyte sedimentation rate and Creactive protein in African-Americans with rheumatoid arthritis. J Rheumatol. 2013;40:18121822.
Tishler M, Yaron I, Geyer O, et al. Elevated tear interleukin–6 levels in patients with Sjogren syndrome. Ophthalmology. 1998;105:2327– 2329.
Tsubota K, Fujihara T, Kaido M, Mori A, Mimura M, Kato M. Dry eye and Meige’s syndrome. Br J Ophthalmol 1997; 81:439–442.
Tsubota K. New approaches to dry-eye therapy. Int Ophthalmol Clin 1994;34:115–128.
Vignesh, Srinivasan. Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clinical Ophthalmology. 2015;9:393-97.
Widdifield, J., Paterson, J. M., Bernatsky, S., Tu, K., Tomlinson, G., Kuriya, B., … Bombardier, C. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis & Rheumatology.2014; 66: 786–793.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.